Post My Press Release

Free Press Release Distribution

Author: rohini (Page 1 of 120)

Pulmonary Inflammation Market Size & Share – Industry Trend and Forecast 2016 – 2024

Global Pulmonary Inflammation Market: Overview

Pulmonary arteries in our body carries deoxygenated blood from our heart to the lungs. Oxygen is added to the blood into the lungs and it (blood) returned to the heart through pulmonary veins. Pulmonary fibrosis is considered as a chronic disease that can cause swelling and scarring of the alveoli (air sacs) and interstitial tissues in the lungs. The scar tissue formed in the lungs can replace healthy tissue and can cause pulmonary inflammation. Due to pulmonary inflammation our lung becomes stiff that makes breathing very difficult. Etiology for pulmonary inflammation includes emphysema, lung cancer, pulmonary fibrosis, embolism, therapeutic radiation, rheumatoid arthritis and sarcoidosis.

Report Overview @ https://www.transparencymarketresearch.com/pulmonary-inflammation-market.html

Breathlessness is identified as the most common symptom of pulmonary inflammation. Dry cough is also considered as very common symptom of pulmonary inflammation. Possible risk factor for suffering from pulmonary inflammation includes cigarette smoking, therapeutic radiation, rheumatoid arthritis and sarcoidosis. Various diagnosis test performed for detection of the pulmonary inflammation includes chest X-ray, pulmonary function test (spirometry), bronchoalveolar lavage test and lung biopsy test. Canadian Lung Association stated that, corticosteroid medication is identified as the most effective treatment for pulmonary inflammation under supervision of a registered medical practitioner. Moreover, it has also stated that, sometimes oxygen therapy is required in order to treat breathlessness.

Global Pulmonary Inflammation Market: Drivers and Restraints

Increasing cigarette smokers and growing prevalence of cancer is considered as a major driving factor of the global pulmonary inflammation treatment market. Moreover, rising prevalence of rheumatoid arthritis cases also accentuates the global market demand of pulmonary inflammation treatment. As an instance, the World Health Organization (WHO) published in 2014, that worldwide 8.2 million people died of cancer in the year 2012. In 2013, American Cancer Society (ACS) published that, around 300,000 men and 276,000 women died due to cancer in 2012 in the U.S. Likewise, emphysema (COPD) is also considered as a major factor that can cause pulmonary inflammation among the global population at a significant rate. Emphysema is mostly caused due to cigarette smoking. According to the Centers for Disease Control and Prevention (CDC), in 2012, North America accounted for the highest number of COPD cases in the world. Moreover, according to the Centers for Disease Control and Prevention (CDC), an estimated 67 million people in the U.S. above 18 years of age would be diagnosed with arthritis by 2030.

Request Brochure @ https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=17159

Thus, rising prevalence of arthritis and cancer would accentuate the global market demand of pulmonary inflammation treatment. However, technical complexity and high cost associated with diagnosis procedure of pulmonary inflammation might restrict the global market demand of pulmonary inflammation to some extent.

Global Pulmonary Inflammation Market: Regional Analysis

North America and Europe was observed to be the largest pulmonary inflammation market due to major market players are based in these regions. Moreover, technological advancement in diagnostic test and strong demand of diagnostic test would also account for the market growth in these regions. In addition, favorable initiative taken by the federal government also accounted for the pulmonary inflammation treatment market growth in North American and European regions.

Similarly, Asia-Pacific is considered as an untapped market due to lack of proper diagnostic facilities in some Asian countries. Asian market growth will be fuelled by the presence of untapped opportunities due to extensive increase in the healthcare infrastructure (healthcare cost, healthcare facility and healthcare budget). Similarly, Asia-Pacific is considered as an emerging market due to growing market penetration in this region. Rest of the world (RoW) holds fourth position in the global pulmonary inflammation treatment market due to poor economic and health condition in most of the African countries.

Request for TOC @ https://www.transparencymarketresearch.com/sample/sample.php?flag=T&rep_id=17159

Global Pulmonary Inflammation Market: Companies Mentioned in the Report

Major market players involved manufacturing the therapeutic product of pulmonary inflammation treatment products and contributing the global market share includes Pharmaxis Limited, InDex Pharmaceuticals AB, Resolvyx Pharmaceuticals, Inc., Idera Pharmaceuticals, Inc., Asmacure Ltee, Celtaxsys, Inc., among others.

The report offers a comprehensive evaluation of the market. It does so via in-depth qualitative insights, historical data, and verifiable projections about market size. The projections featured in the report have been derived using proven research methodologies and assumptions. By doing so, the research report serves as a repository of analysis and information for every facet of the market, including but not limited to: Regional markets, technology, types, and applications.

About Us

Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants, use proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.

Each TMR syndicated research report covers a different sector – such as pharmaceuticals, chemicals, energy, food & beverages, semiconductors, med-devices, consumer goods and technology. These reports provide in-depth analysis and deep segmentation to possible micro levels. With wider scope and stratified research methodology, TMR’s syndicated reports strive to provide clients to serve their overall research requirement.

Contact Us

Transparency Market Research

90 State Street, Suite 700

Albany, NY 12207

Tel: +1-518-618-1030

USA – Canada Toll Free: 866-552-3453

Email: sales@transparencymarketresearch.com

Website: https://www.transparencymarketresearch.com

Haemophilus Infections Market Current Trends & Opportunities by 2020

Haemophilus is a group of bacteria that causes different types of illness such as breathing, bone and joint disorders and nervous system disorders. Among all the strains of Haemophilus, H infleunzae type b (Hib) is one of the most common types of infecton causing bacteria. The bacteria is also known as Bacillus Influenzae of Pfeiffer’s bacillus and it is a gram negative, facultatively, ccobacillary, anaerobic bacteria. This strain of bacterium belongs to the Pasteurellaceae family and was first isolated in 1892 during influenza pandemic. Some strains of the H. infleunzae posses a capsule of polysaccharide and on the basis of different biochemical properties of capsule these strains are classified into 6 different subtypes. Among all the strains of Haemophilus, H infleunzae type b (Hib) is the most virulent strain that is responsible for invasive infections. However, there are some strains of Haemophilus that have no capsule and can be termed as non encapsulated or nontypeable H.infleunzae. This strain of bacteria accounts for more than 95% of the infections occurring due to Haemophilus influenza in adults and children. H. infleunzae is also responsible for wide range of invasive and localized infections which can range from mild ear infection to other sever infections like blood stream infections. This strain can cause cellulitis, meningitis, epiglottis, urinary tract infections, septic arthritis, cervical adenitis, endocartis, osteomyelitis and glossitis. Infection caused by non encapsulated H.infleunzae strain includes sinusitis, pneumonia, bronchitis, otitis media and mucosal infections.

Report Overview @ https://www.transparencymarketresearch.com/haemophilus-infections-market.html

Hib is a communicable disease and is spread through saliva or mucus. Most of the infections are found to communicate through sneezing or coughing. Thus, for the prevention of influenza infection, vaccination is one of the most common modes of treatment recommended. Thus, children under age of 5 are the most common victim for influenza who haven’t been vaccinated before. According to the WHO in 2000, Hib infections were responsible for cause of approximately 3 million cases of serious infections such as meningitis and pneumonia across the globe. Likewise, the infection also caused 386,000 deaths in young children worldwide. Thus, routine immunization against Haemophilus infection is used in over 100 countries. Additionally, diagnostic tests such as bacterial gram staining, blood cell counts, cerebrospinal fluid studies and others are the major laboratory testing studies performed. Similarly, computed tomography, chest radiography, echocardiography and lateral neck radiography are some of the imaging studies performed to confirm the infection. However, immunization or vaccination remains the major treatment for the prevention of Hib infections. Thus, most of the companies have their drug candidates in the pipeline and are expected to launch in the future.

Request Brochure @ https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=3065

Rising incidences of Haemophilus Influenzae infection is one of the major causes for the growth of this market. In Japan every year more than 450 children, under the age of 5 years are affected by Hib meningitis. Similarly in the United States the overall incidence of Hib meningitis in children aged 0 years to 4 years 40 to 50 per 10,000. Thus, overall increasing incidences of Haemophilus influezae infection is luring many manufacturers to enter in this market. For, instance HibTITER a first conjugate vaccine proved to be successful in reducing the incidences of H.influenzae. Currently, Nuron Biotech has entered into partnership with Mitsubishi Corporation for the development of single antigen and conjugate vaccine against Hib infection for the Japanese market.

Request for TOC @ https://www.transparencymarketresearch.com/sample/sample.php?flag=T&rep_id=3065

Takeda Pharmaceuticals, GlaxoSmith Kline Plc, Sanofi, Inc., Novartis AG, Biological E. Limited, Panacea Biotech Limited, Zydus Cadila Healthcare Limited, Nuron Biotech, Inc., Sinovac Biotech Limited and others are some of the major players operating in this segment.

About Us

Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants, use proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.

Each TMR syndicated research report covers a different sector – such as pharmaceuticals, chemicals, energy, food & beverages, semiconductors, med-devices, consumer goods and technology. These reports provide in-depth analysis and deep segmentation to possible micro levels. With wider scope and stratified research methodology, TMR’s syndicated reports strive to provide clients to serve their overall research requirement.

Contact Us

Transparency Market Research

90 State Street, Suite 700

Albany, NY 12207

Tel: +1-518-618-1030

USA – Canada Toll Free: 866-552-3453

Email: sales@transparencymarketresearch.com

Website: https://www.transparencymarketresearch.com

Hybrid Imaging Systems Market Growth, Capacity, Scope, Revenue, Key-Players, and Forecast until 2025

Hybrid imaging is fusion of two or more imaging technologies into a single new form. The image obtained with hybrid imaging system is more powerful in terms of accuracy as compared to two single images. Along with depicting the anatomy, hybrid imaging enables visualization of the molecular processes in vivo within larger anatomic content. Technologies in hybrid imaging include ultrasonography, magnetic resonance imagining (MRI), computed tomography (CT), and positron emission tomography (PET). The fusion of these technologies have given rise to hybrid imaging systems. The hybrid of PET/CT was introduced in 2001 and SPECT/CT was introduced in 2003. PET/MRI is also an available hybrid imaging system, but not used widely. Both hybrid imaging techniques PET/CT and SPECT/CT have significant relevance in clinical and pre-clinical practice. Hybrid imaging scans need a patient to be stationed at the same place for both scans. Involuntary movements of the internal organs can be minimized in hybrid imaging systems. Hybrid imaging systems have reduced the time required for scanning. Usually the required time with standalone imaging systems is an hour or even more. However, hybrid imaging systems have reduced scanning time by up to 25 minutes to 30 minutes. With the emergence of hybrid imaging system, a patient can be scanned in a single session and the desired anatomical and functional data of the organ of interest can be achieved. PET/CT has evolved due to continuous innovation, which enables more accurate measurements of metabolic processes, data quantification and analysis of neurologic disease, cancerous tissue, and cardiac blood flow. PET/CT is a standard hybrid imaging technique used in oncology and SPECT/CT, which is in an evolving phase, is generally used for cardiac scans.

Report Overview @ https://www.transparencymarketresearch.com/hybrid-imaging-systems-market.html

Rise in importance of combination analysis of anatomic and molecular data in the diagnosis of diseases is a major driver of the global hybrid imaging systems market. Further with the benefits of hybrid imaging and its rising use in the diagnosis, there is huge potential for the of combination hybrid imaging PET or SPECT with MRI. Increase in prevalence of chronic diseases, growing awareness about early diagnosis, and rise in the number of diagnostic procedures are propelling the market. Site accreditation, technologist training, physician training, and high cost for procedure among the underprivileged population are the major restraints of the global hybrid imaging systems market.

The global hybrid imaging systems market can be segmented based on technology, application, end-user, and region. In terms of technology, the market can be categorized into PET/CT, SPECT/CT, and PET/MRI. By applications the segment PET/CT scan, used for diagnosis in the field of oncology, neurology and cardiology, whereas, SPECT/CT scans are done for the diagnosis of infections, inflammation, thyroid disorders, oncology and orthopedic problems. In terms of end-user, the market can be bifurcated into hospitals and diagnostic centers. In terms of region, the global hybrid imaging systems market can be segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa.

Request Brochure @ https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=35696

In the past five years, standalone systems have been replaced by hybrid imaging systems, a trend observed globally. Highest number of installations of PET/CT were seen in the U.S. Western Europe reported increase in PET/CT scans by 72% in 2008; installations of SPECT/CT were lesser than PET/CT. The Middle East is an emerging market for hybrid imaging systems. In North America, hybrid scanning system is highly preferred in the diagnosis of cardiology and global nuclear medicine market. This trend is also predominant in Europe and Asia Pacific. Countries in Asia are also expected to witness growth in the next few years due to rise in awareness about early diagnosis of life threatening diseases and advancements in nuclear medicine. Latin America and Middle East & Africa are potential markets. Growth in these regions is attributed to low disposable income and significant contribution of government investment in health care.

Leading players in the global hybrid imaging systems market are Siemens Healthineers, GE Healthcare, Philips Healthcare, Hitachi Ltd., Atlantis Worldwide, Shared Imaging, and Amber Diagnostic, Inc.

Request for TOC @ https://www.transparencymarketresearch.com/sample/sample.php?flag=T&rep_id=35696

The report offers a comprehensive evaluation of the market. It does so via in-depth qualitative insights, historical data, and verifiable projections about market size. The projections featured in the report have been derived using proven research methodologies and assumptions. By doing so, the research report serves as a repository of analysis and information for every facet of the market, including but not limited to: Regional markets, technology, types, and applications.

About Us

Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants, use proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.

Each TMR syndicated research report covers a different sector – such as pharmaceuticals, chemicals, energy, food & beverages, semiconductors, med-devices, consumer goods and technology. These reports provide in-depth analysis and deep segmentation to possible micro levels. With wider scope and stratified research methodology, TMR’s syndicated reports strive to provide clients to serve their overall research requirement.

Contact Us

Transparency Market Research

90 State Street, Suite 700

Albany, NY 12207

Tel: +1-518-618-1030

USA – Canada Toll Free: 866-552-3453

Email: sales@transparencymarketresearch.com

Website: https://www.transparencymarketresearch.com

Medical Electronics Market: Size, Share, Emerging Trends, Analysis and Forecasts to 2025

Electronic devices are increasingly used for therapy, diagnosis, and rehabilitation in the field of medicine. Electromechanical equipment and medical electronics have become indispensable for providing better services to patients. Medical electronics is a branch of electronics in which medical equipment and instruments are used for medical applications such as research, diagnosis, therapy, anesthesia control, surgery, and cardiac control. Medical electronics engineering integrates medicine and environmental science with engineering practices and theories. Semiconductors have become an integral part of medical electronics equipment for reducing the cost which is changing the affordability of equipments. Medical electronic equipment are indispensable for proving better services to patients in hospitals. In medical electronics by using precise and sophisticated equipment, medical science examines, cures and treats almost all the diseases. Benefits associated with the use of medical electronic technologies include remote health data availability, precise billing mechanism, improvement in the quality of health care, increase in output accuracy, easy to update patient records, and rise in the level of patient experience. Rapid advancement in IT and increasing health care consciousness has accelerated the scope for medical electronics market. Advanced technology in medical electronics include telehealth in intensive care unit (ICU), emergency department (ED) and hospital ward and skilled nursing facility (SNF). With the advent of digital stethoscopes, digital X-ray systems and handheld smart phone-sized ultrasound systems, conventional medical devices have evolved to aid medical electronics market. Rapid advancement in health care consciousness and information technology has accelerated the scope for medical electronics market. Growth in medical electronics market is influencing various demographic trends such as enhanced portability of complex monitoring and imaging systems, increase in household medical electronics equipment, and functional integration of applications and equipment in network and wireless technology.

Report Overview @ https://www.transparencymarketresearch.com/medical-electronics-market.html

Rising geriatric population and increasing use of respiratory care devices are fuelling the medical electronics market. Additionally, factors such as demand for easy-to-use, personalized & advanced healthcare devices, changing lifestyle, and rising adoption of wearable electronics are expected to drive the medical electronics market. However, issues regarding cybersecurity, where health care providers and patients are subjected to security breaches and malware infections are expected to hinder the market. Rising demand for better and improved health care and developments in newer medical technologies for wireless medical devices and its technology are expected boost the medical electronics market. Moreover, factors such as increased market penetration rate of portable medical devices, increasing trend of remote patient monitoring, and high availability of electronic components such as memory devices, display technologies and microcontrollers are expected to create growth opportunities for medical electronics market. With advancement in technology, newer medical electronics devices are emerging in healthcare which is also expected to boost growth in medical electronics market.

Request Brochure @ https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=34568

The global medical electronics market can be segmented based on product type, application, component, and region. In terms of product type, the market can be segmented into invasive and non-invasive. Based on application, the market is classified into diagnosis, monitoring, and treatment. In terms of component, the market is categorized into sensors, batteries, memory devices, microcontrollers, and displays. Based on geography the global medical electronics market is segmented into North America, Asia Pacific, Middle-East & Africa (MEA), South America, and Europe. North America is expected to dominate the market during the forecast period owing to the increase in demand for medical electronics and improved health care infrastructure.

Key players operating in the global medical electronics market are Texas Instruments Inc., GE Healthcare Pvt. Ltd, STMicroelectronics N.V., NXP Semiconductors N.V., Medtronic PLC., Cypress Semiconductor Corporation, Analog Devices, Inc., On Semiconductor Corporation, Siemens Healthcare Private Limited, and Philips Healthcare Pvt. Ltd.

Request for TOC @ https://www.transparencymarketresearch.com/sample/sample.php?flag=T&rep_id=34568

The report offers a comprehensive evaluation of the market. It does so via in-depth qualitative insights, historical data, and verifiable projections about market size. The projections featured in the report have been derived using proven research methodologies and assumptions. By doing so, the research report serves as a repository of analysis and information for every facet of the market, including but not limited to: Regional markets, technology, types, and applications.

About Us

Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants, use proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.

Each TMR syndicated research report covers a different sector – such as pharmaceuticals, chemicals, energy, food & beverages, semiconductors, med-devices, consumer goods and technology. These reports provide in-depth analysis and deep segmentation to possible micro levels. With wider scope and stratified research methodology, TMR’s syndicated reports strive to provide clients to serve their overall research requirement.

Contact Us

Transparency Market Research

90 State Street, Suite 700

Albany, NY 12207

Tel: +1-518-618-1030

USA – Canada Toll Free: 866-552-3453

Email: sales@transparencymarketresearch.com

Website: https://www.transparencymarketresearch.com

Steam Autoclave Market to Surge at a CAGR of 5.7% from 2016 to 2024

Steam Autoclave Market: Overview

The global demand for steam autoclaves is increasing and the main reason behind this is the growing incidences of infectious diseases and a staggering surge in the number of cases of hospital-acquired infections. The spread of infectious diseases has also led to a demand for improvement in the healthcare services in developing nations of Asia Pacific. The growing geriatric population and growing healthcare expenditure in this region will help bolster the demand for steam autoclave market.

Report Overview @ https://www.transparencymarketresearch.com/steam-autoclave-market.html

Steam Autoclave Market: Trends and Opportunities

The affluent population base is increasingly demanding high quality healthcare services and this will stimulate the growth of the global steam autoclave market in the coming years. The healthcare infrastructure requires improvement in parts of Latin America and Asian countries such as China and India. This will provide ample growth opportunities for the steam autoclave market in these parts of the world.

The traditional steam autoclave systems segment is expected to account for a high percentage of the total market, leaving behind the tabletop steam autoclaves market segment. During the entire forecast period, the dominance of traditional steam autoclave systems will ensue. The extensive use of these systems across applications such as medical devices and pharmaceutical laboratories will drive their demand. In addition to this, traditional steam autoclaves are highly efficient for simultaneously sterilizing medical devices in large numbers, boosting their demand further.

Request A Sample Copy @ https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=3997

Steam Autoclave Market: Geography

On the basis of geography, North America is leading in the steam autoclave market and is expected to continue to do so in the coming years. Europe will trail after North America in terms of leading regional market. Strict rules for the safety of patients at healthcare organizations will lead to a heightened adoption of steam autoclaves in Europe. With a CAGR of 7.9% CAGR from 2016 to 2024, it will be Asia Pacific to witness the fastest growth in the coming years, followed by Latin America, which is estimated to expand at a 6.9% during the same period.

Request Brochure @ https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=3997

Steam Autoclave Market: Company Profiling

Highly competitive and consolidated are two characteristics that describe the global steam autoclave market correctly. The leading companies account a major share of the market, making it very difficult for new players to enter the market. The top three companies, STERIS, Getinge Group, and Johnson & Johnson accounted for a share of over 70% in 2015. Some of the other players within the market are: Other prominent vendors in the market include Matachana Group, CISA Group, Belimed Group, SAKURA SI CO., LTD., and 3M Health Care. Great growth opportunities of growth lie for companies introducing innovative and technologically advanced products. This has been proven by the high success of products based on the use of technologies such as E-beam and gamma irradiation.

About Us

Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants, use proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.

Each TMR syndicated research report covers a different sector – such as pharmaceuticals, chemicals, energy, food & beverages, semiconductors, med-devices, consumer goods and technology. These reports provide in-depth analysis and deep segmentation to possible micro levels. With wider scope and stratified research methodology, TMR’s syndicated reports strive to provide clients to serve their overall research requirement.

Contact Us

Transparency Market Research

90 State Street, Suite 700

Albany, NY 12207

Tel: +1-518-618-1030

USA – Canada Toll Free: 866-552-3453

Email: sales@transparencymarketresearch.com

Website: https://www.transparencymarketresearch.com

Europe Molecular Diagnostic Market to Attain a Value of US$ 22.3 Mn by 2023

Nucleic acid tests are used for rapid and accurate identification of microbes. This report on molecular diagnostic market for group A streptococcus (GAS) nucleic acid (NA) test products in Europe analyses the current and future prospects of the market. The report comprises an elaborate executive summary, including a market snapshot that provides overall information of various segments and sub-segments. This section also provides the overall information and data analysis of the nucleic acid test products market in Europe with respect to the leading market segments based on type of test techniques, end-user, and geography.

The market overview section of the report includes qualitative analysis of the nucleic acid test product market in Europe including the factors determining the market dynamics such as drivers, restraints, and opportunities, along with Porter’s Five Forces Analysis. In addition, various analyses such as market attractiveness analysis by geography and competitive landscape by key players have been provided. The market attractiveness analysis explains the intensity of competition in the market in different geographies. The competitive scenario between market players is evaluated through market share analysis. These factors would help the market players to take strategic decisions in order to strengthen their positions and expand their shares in the European market.

Request A Sample Copy @ https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=10505

The nucleic acid test product market in Europe has been segmented based on type of test technique, end-user, and geography. Based on type of test technique, the nucleic acid test market has been categorized into three major segments: polymerase chain reaction, non-amplified tests, and isothermal nucleic acid amplification technology. Based on end-user, the nucleic acid test product market in Europe has been segmented into five types: Hospitals, public health laboratories, and others. Market revenue in terms of US$ Mn for the period between 2013 and 2023 along with the compound annual growth rate (CAGR %) from 2015 to 2023 is provided for all the segments, considering 2014 as the base year.

Request Brochure @ https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=10505

Geographically, the nucleic acid test product market in Europe has been categorized into five regions: Western Europe, Northern Europe, Southern Europe, Eastern Europe, and Rest of Europe. Western Europe comprises France, Germany, Austria, and Rest of Western Europe. Northern Europe includes Ireland, Norway, Sweden, the U.K. and Northern Ireland, and Rest of Central Europe. Southern Europe comprises Italy, Spain, Portugal, and Rest of Southern Europe. Eastern Europe comprises Poland, the Czech Republic, Ukraine, Russian Federation, and Rest of Eastern Europe. The recommendations section included in the report would assist existing players to expand their market share and new companies to establish their presence in the market. The report also profiles major players in the nucleic acid test product market in Europe based on various attributes such as company overview, financial overview, business strategies, product portfolio, and recent developments. Major players profiled in this report include Alere, Inc., F. Hoffmann-La Roche Ltd., Hologic, Inc., Meridian Bioscience, Inc., Nanosphere, Inc., and Quidel Corporation.

About Us

Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants, use proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.

Each TMR syndicated research report covers a different sector – such as pharmaceuticals, chemicals, energy, food & beverages, semiconductors, med-devices, consumer goods and technology. These reports provide in-depth analysis and deep segmentation to possible micro levels. With wider scope and stratified research methodology, TMR’s syndicated reports strive to provide clients to serve their overall research requirement.

Contact Us

Transparency Market Research

90 State Street, Suite 700

Albany, NY 12207

Tel: +1-518-618-1030

USA – Canada Toll Free: 866-552-3453

Email: sales@transparencymarketresearch.com

Website: https://www.transparencymarketresearch.com

Blood Collection Tubes Market Will be Worth US$ 632.1 Mn by 2023

Blood collection tube is a plastic or glass tube that is without any infection or contamination. These tubes also have a closure, which is evacuated in order to build a vacuum in the interior of the tube, which in turn enables drawing an exact liquid volume from the patient. These tubes are primarily used to collect blood samples. However, they can also be used to collect urine samples as well as serum separator tubes. The North American market for blood collection tubes is gaining traction from a number of factors including the escalating demand from aging population for blood products and increasing number of complex surgical procedures.

Report Overview @ https://www.transparencymarketresearch.com/north-america-blood-collection-tubes-market.html

The blood collection tubes market in North America was worth US$300.8 mn in 2014, which is estimated to reach a valuation of US$632.1 mn by 2023, expand at a robust CAGR of 8.6% during the forecast period of 2015 to 2023. The prosperity of this market can be attributed to the vast opportunities available for the players in the form of advanced screening tests, implementation of new blood collection techniques, and advent of automation in the process of collection of blood. These are some of the key factors anticipated to cater a significant demand in the North America market for blood collection tubes across North American countries such as the U.S. and Canada. On the other hand, stringent regulatory guidelines and healthcare policies will also reflect positively on the market during the forecast period as manufacturers are frequently coming up with new and safer technologies in order to collect blood. In addition to that, North America makes for a developed region, and thereby has high level of awareness among the consumers such as hospitals and diagnostic centers. This factor, as well as the subsidies offered by the government in the U.S. and Canada and advancements in blood collection technologies is expected to favor the market in a long-term.

Request A Sample Copy @ https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=8689

Serum Separating Tubes In-Demand Segment

Based on product type, the global blood collection tubes market has been segmented into herapin tubes, plasma separation tube, EDTA tubes, serum separating tubes, rapid serum tubes, and others. Among these, the serum separating tubes segment accounted for 39.6% shares of the market in 2014, which was a result of utilization of diagnosis purposes across North America and utilization of diagnosis purposes across North America and increasing number of serum samples collected. Serum separating tubes utilize a particular gel that helps in separating blood cells from serum, and also contains particles that cause blood to clot easily. Serum is used to detect the presence of a particular antibody, antigen, hormone, and exogenous substances. Apart from that, the segment of rapid serum tubes is anticipated to increase at a higher rate during the forecast period, which is a result of advent of advanced technologies and incremented efficiency offered by the product.

Request Brochure @ https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=8689

The U.S. Most Lucrative Market by a Country-mile

The U.S. is the most lucrative country in the North America blood collection tubes market, accounting for 84.6% of the demand, which is primarily a reflection of increasing geriatric population along with the prevalence of various diseases. In addition to that, the increasing government initiatives in the country of the U.S. is expected to drive this market further. For example, introduction of patient protection affordable care act (PPACA) in March 2010 provides healthcare coverage to more than 94% of Americans. Canada is the second most profitable country in the North America blood collection tubes market.

The North America blood collection tubes market is consolidated with a Becton Dickinson and Company being the pioneer and industry leader with 95% of the market in 2014. With a strong product portfolio of pre-analytical systems, BD is expected to maintain its stronghold in the near future. Terumo Corporation and Qiagen N.V. are some of the other prominent companies operating in this market.

About Us

Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants, use proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.

Each TMR syndicated research report covers a different sector – such as pharmaceuticals, chemicals, energy, food & beverages, semiconductors, med-devices, consumer goods and technology. These reports provide in-depth analysis and deep segmentation to possible micro levels. With wider scope and stratified research methodology, TMR’s syndicated reports strive to provide clients to serve their overall research requirement.

Contact Us

Transparency Market Research

90 State Street, Suite 700

Albany, NY 12207

Tel: +1-518-618-1030

USA – Canada Toll Free: 866-552-3453

Email: sales@transparencymarketresearch.com

Website: https://www.transparencymarketresearch.com

Cardiac Pacemaker Market to Reach an Opportunity of US$ 12.5 Bn by the End of 2023

Global Cardiac Pacemaker Market: Snapshot

By 2030, nearly 20% of the total U.S. population is expected to be made up of geriatrics, according to the U.S. Census Board. This is a huge growth in the number of elderly citizens in this country, and similar cases are being witnessed in most developed economies and a few developing ones as well. This rise in the geriatric population is expected to be the greatest driver for a lot of healthcare industry segments, including the market of cardiac pacemakers.

Report Overview @ https://www.transparencymarketresearch.com/cardiac-pacemakers-market.html

At the same time, the number of patients with heart complications is increasing significantly due to inculcation of modern lifestyles that can lead to obesity and high stress. Both factors are primarily responsible for the increasing demand for cardiac pacemakers among those younger than 65 years.

However, manufacturers of cardiac pacemakers also have to face problems such as the complex and time consuming approval procedure for sales of cardiac pacemakers due to their high risk nature of use. Additionally, players also have to significantly reduce their profit margins due to the implementation of policies such as the Affordable Healthcare Act in the U.S.

As a result of the given factors, the global revenue generated from cardiac pacemakers is expected to reach US$12.8 bn by the end of 2023, according to Transparency Market Research. In terms of volume, the total number of cardiac pacemakers consumed globally will cross 2.4 mn units.

Request A Sample Copy @ https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=393

Asia Pacific Shows High Growth Scope in Cardiac Pacemaker Demand

Based on the current trends in cardiac pacemaker supply and demand chains, Asia Pacific is expected to show the fastest growth rate, ending up with a share in volume of 20.3% by the end of 2023. The key factors responsible for the growth in cardiac pacemaker sales in this region include the growth in awareness of modern pacemakers and the increasing number of heart disease patients across the region.

Europe, however, is expected to retain its leading position for the number of cardiac pacemakers consumed. This region is expected to hold a volume share of 51.1% in 2023 due to a high percentage of the elderly and other heart disease patients. In terms of revenue, North America leads the global market for cardiac pacemakers.

Implantable Pacemakers Most Preferred Type Globally

Almost all of the cardiac pacemakers used in the world today are implantable as there are very few cases where external cardiac pacemakers would be required. Most patients with heart problems require implantable pacemakers. This segment is also expected to show the fastest growth rate for the coming few years due to a high global demand for advanced implantable cardiac pacemakers. The total revenue generated through implantable cardiac pacemakers is expected to reach US$12.5 bn by the end of 2023.

Request Brochure @ https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=393

Most of the heart problem indicators point to the need for a permanent pacemaker. These include a complete atrio-ventricular blockage, symptomatic sinus bradycardia, and sick sinus syndrome. Sick sinus syndrome is additionally the most common illness faced by European patients in need of cardiac pacemakers.

The key companies in the cardiac pacemakers market include Medtronic, St. Jude Medical, Boston Scientific, Biotronik, and Sorin. A very small share of the cardiac pacemakers market is taken up by regional players, as the above leader constitute most of the global supply currently.

About Us

Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants, use proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.

Each TMR syndicated research report covers a different sector – such as pharmaceuticals, chemicals, energy, food & beverages, semiconductors, med-devices, consumer goods and technology. These reports provide in-depth analysis and deep segmentation to possible micro levels. With wider scope and stratified research methodology, TMR’s syndicated reports strive to provide clients to serve their overall research requirement.

Contact Us

Transparency Market Research

90 State Street, Suite 700

Albany, NY 12207

Tel: +1-518-618-1030

USA – Canada Toll Free: 866-552-3453

Email: sales@transparencymarketresearch.com

Website: https://www.transparencymarketresearch.com

Page 1 of 120

Powered by WordPress & Theme by Anders Norén